Valuation: Ipca Laboratories Limited

Market Cap 454B 4.75B 4.17B 3.88B 3.57B 6.69B 6.81B 46.06B 18.03B 225B 17.84B 17.45B 778B P/E 2027 *
32.5x
P/E 2028 * 27.3x
Enterprise Value 442B 4.63B 4.06B 3.78B 3.48B 6.52B 6.63B 44.86B 17.56B 219B 17.37B 17B 757B EV / Sales 2027 *
4.1x
EV / Sales 2028 * 3.58x
Free-Float
54.92%
Yield 2027 *
0.32%
Yield 2028 * 0.35%
1 day-0.46%
1 week-0.44%
Current month+4.69%
1 month+8.10%
3 months+15.47%
6 months+20.34%
Current year+25.50%
1 week 1,725
Extreme 1725
1,808
1 month 1,635.8
Extreme 1635.8
1,944.9
Current year 1,391.8
Extreme 1391.8
1,944.9
1 year 1,251.6
Extreme 1251.6
1,944.9
3 years 847.3
Extreme 847.3
1,944.9
5 years 669.8
Extreme 669.8
1,944.9
10 years 200
Extreme 200
1,944.9
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%-0.44%+19.63%+103.86% 4.75B
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
+0.16%+10.71%+41.81%+35.99% 359B
+0.33%+4.72%+38.58%+44.13% 303B
+1.28%+3.24%+17.53%+17.24% 267B
-0.15%+4.57%-3.69%-38.82% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
Average +1.40%+4.51%+31.43%+59.71% 373.59B
Weighted average by Cap. +1.56%+5.13%+40.99%+79.97%

Financials

2027 *2028 *
Net sales 108B 1.13B 989M 921M 847M 1.59B 1.62B 10.93B 4.28B 53.41B 4.23B 4.14B 185B 120B 1.26B 1.1B 1.03B 945M 1.77B 1.8B 12.19B 4.77B 59.55B 4.72B 4.62B 206B
Net income 14B 147M 129M 120M 110M 206M 210M 1.42B 556M 6.94B 550M 538M 23.99B 16.7B 175M 153M 143M 131M 246M 250M 1.69B 663M 8.28B 656M 642M 28.61B
Net Debt -11.82B -124M -109M -101M -93.03M -174M -177M -1.2B -470M -5.86B -465M -455M -20.26B -23.66B -248M -217M -202M -186M -349M -355M -2.4B -940M -11.73B -930M -910M -40.54B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
29/07/26 1,781.10 -0.44% 58,145
28/07/26 ₹1,789.00 +0.64% 238,234
27/07/26 ₹1,777.60 +0.85% 119,666
24/07/26 ₹1,762.70 -0.48% 79,195
23/07/26 ₹1,771.20 -0.97% 162,968
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,789.00INR
Average target price
1,733.50INR
Spread / Average Target
-3.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock